U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C46H91NO4
Molecular Weight 722.219
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of N-(2'-(S)-hydroxylignoceroyl)-D-erythro-C22-sphingosine

SMILES

CCCCCCCCCCCCCCCCCCCCCC[C@H](O)C(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCCCCCC

InChI

InChIKey=NLOGNBRPPDJNTF-ITEXHMEUSA-N
InChI=1S/C46H91NO4/c1-3-5-7-9-11-13-15-17-19-21-22-23-25-27-29-31-33-35-37-39-41-45(50)46(51)47-43(42-48)44(49)40-38-36-34-32-30-28-26-24-20-18-16-14-12-10-8-6-4-2/h38,40,43-45,48-50H,3-37,39,41-42H2,1-2H3,(H,47,51)/b40-38+/t43-,44+,45-/m0/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
N-(2'-(S)-hydroxylignoceroyl)-D-erythro-C22-sphingosine
Systematic Name English
C24 (2’(S)-hydroxy) Ceramide (d22:1/24:0)
Preferred Name English
Tetracosanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heneicosen-1-yl]-, (2S)-
Systematic Name English
(2S)-2-Hydroxy-N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heneicosen-1-yl]tetracosanamide
Systematic Name English
Code System Code Type Description
FDA UNII
DZP2AQQ6RQ
Created by admin on Wed Apr 02 19:45:18 GMT 2025 , Edited by admin on Wed Apr 02 19:45:18 GMT 2025
PRIMARY